Polpharma European CDMO Partner & API Manufacturer since 1951 Polpharma European CDMO Partner & API Manufacturer since 1951

X

CAS 219823-47-9 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 219823-47-9
Also known as: 219823-47-9, (3r)-tetrahydrofuran-3-yl 4-methylbenzenesulfonate, A4fnd4p2ym, [(3r)-oxolan-3-yl] 4-methylbenzenesulfonate, (r)-toluene-4-sulfonic acid tetrahydrofuran-3-yl ester, (3r)-oxolan-3-yl 4-methylbenzene-1-sulfonate
Molecular Formula
C11H14O4S
Molecular Weight
242.29  g/mol
InChI Key
WWCNXHYRAKUQDB-SNVBAGLBSA-N
FDA UNII
A4FND4P2YM

1 2D Structure

CAS 219823-47-9

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[(3R)-oxolan-3-yl] 4-methylbenzenesulfonate
2.1.2 InChI
InChI=1S/C11H14O4S/c1-9-2-4-11(5-3-9)16(12,13)15-10-6-7-14-8-10/h2-5,10H,6-8H2,1H3/t10-/m1/s1
2.1.3 InChI Key
WWCNXHYRAKUQDB-SNVBAGLBSA-N
2.1.4 Canonical SMILES
CC1=CC=C(C=C1)S(=O)(=O)OC2CCOC2
2.1.5 Isomeric SMILES
CC1=CC=C(C=C1)S(=O)(=O)O[C@@H]2CCOC2
2.2 Other Identifiers
2.2.1 UNII
A4FND4P2YM
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 219823-47-9

2. (3r)-tetrahydrofuran-3-yl 4-methylbenzenesulfonate

3. A4fnd4p2ym

4. [(3r)-oxolan-3-yl] 4-methylbenzenesulfonate

5. (r)-toluene-4-sulfonic Acid Tetrahydrofuran-3-yl Ester

6. (3r)-oxolan-3-yl 4-methylbenzene-1-sulfonate

7. 4-methylbenzenesulfonic Acid (3r)-oxolan-3-yl Ester

8. Tetrahydrofuran-3-yl 4-methylbenzenesulfonate, (3r)-

9. 3-furanol, Tetrahydro-, 3-(4-methylbenzenesulfonate), (3r)-

10. Mfcd27947543

11. Unii-a4fnd4p2ym

12. Schembl507364

13. Zinc34165052

14. Ac-29063

15. Bs-16642

16. Cs-0106178

17. R)-3-(p-toluenesulfonyl) Oxytetrahydrofuran

18. (3r)-oxolan-3-yl4-methylbenzene-1-sulfonate

19. (r)-tetrahydrofuran-3-yl4-methylbenzenesulfonate

20. (r)-3-(4-methylphenylsulfonyloxy)-tetrahydrofuran

21. (r)-tetrahydrofuran-3-yl-4-methylbenzenesulfonate

22. (r)-3-(4-methylphenyl-sulfonyloxy)-tetrahydrofuran

23. (r)-3-[(4-methylphenyl)sulphonyloxy]-tetrahydrofuran

24. [(3r)-tetrahydrofuran-3-yl] 4-methylbenzenesulfonate

25. P-toluenesulfonic Acid (r)-tetrahydrofuran-3-yl Ester

26. (r)-toluene-4-sulfonic Acid Tetrahydro-furan-3-yl Ester

27. Toluene-4-sulfonic Acid (r)-(tetrahydro-furan-3-yl) Ester

28. Toluene-4-sulfonic Acid (r)-(tetrahydro-furan-3-yl)ester

2.4 Create Date
2006-10-26
3 Chemical and Physical Properties
Molecular Weight 242.29 g/mol
Molecular Formula C11H14O4S
XLogP31.6
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count4
Rotatable Bond Count3
Exact Mass242.06128010 g/mol
Monoisotopic Mass242.06128010 g/mol
Topological Polar Surface Area61 Ų
Heavy Atom Count16
Formal Charge0
Complexity311
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag China
Digital Content Digital Content
URL Supplier Web Content
915095-89-5
Empagliflozin
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
32384-65-9
Empagliflozin
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
864070-18-8
Empagliflozin
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY